Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To develop a patient-based, linearly weighted scale that captures activity and social participation limitations in patients with Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and gammopathy-related polyneuropathy (MGUSP).
Methods: A preliminary Rasch-built Overall Disability Scale (R-ODS) containing 146 activity and participation items was constructed, based on the WHO International Classification of Functioning, Disability and Health, literature search, and patient interviews. The preliminary R-ODS was assessed twice (interval: 2–4 weeks; test-retest reliability studies) in 294 patients who experienced GBS in the past (n = 174) or currently have stable CIDP (n = 80) or MGUSP (n = 40). Data were analyzed using the Rasch unidimensional measurement model (RUMM2020).
Results: The preliminary R-ODS did not meet the Rasch model expectations. Based on disordered thresholds, misfit statistics, item bias, and local dependency, items were systematically removed to improve the model fit, regularly controlling the class intervals and model statistics. Finally, we succeeded in constructing a 24-item scale that fulfilled all Rasch requirements. “Reading a newspaper/book” and “eating” were the 2 easiest items; “standing for hours” and “running” were the most difficult ones. Good validity and reliability were obtained.
Conclusion: The R-ODS is a linearly weighted scale that specifically captures activity and social participation limitations in patients with GBS, CIDP, and MGUSP. Compared to the Overall Disability Sum Score, the R-ODS represents a wider range of item difficulties, thereby better targeting patients with different ability levels. If responsive, the R-ODS will be valuable for future clinical trials and follow-up studies in these conditions.
Footnotes
-
Study funding: GBS-CIDP Foundation International and Talecris Talents program.
-
Supplemental data at www.neurology.org
-
- ALDS
- AMC Linear Disability Score
- CI
- confidence interval
- CIDP
- chronic inflammatory demyelinating polyradiculoneuropathy
- CTT
- classic test theory
- DIF
- differential item functioning
- GBS
- Guillain-Barré syndrome
- ICF
- International Classification of Functioning, Disability and Health
- IRT
- item response theory
- MGUSP
- gammopathy-related polyneuropathy
- MMN
- multifocal motor neuropathy
- ODSS
- Overall Disability Sum Score
- PSI
- Person Separation Index
- R-ODS
- Rasch-built Overall Disability Scale
- RUMM2020
- Rasch unidimensional measurement model
- VSN
- Vereniging Spierziekten Nederland
- Received April 27, 2010.
- Accepted September 24, 2010.
- Copyright © 2011 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Dr. Kathleen Digre and Dr. Kendra Pham
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Changing outcome in inflammatory neuropathiesRasch–comparative responsivenessThomas H.P. Draak, Els K. Vanhoutte, Sonja I. van Nes et al.Neurology, November 05, 2014 -
Articles
Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathiesIngemar S. J. Merkies, Paul I. M. Schmitz, Frans G. A. van der Meché et al.Neurology, February 22, 2000 -
Articles
Fatigue in immune-mediated polyneuropathiesI.S. J. Merkies, P.I. M. Schmitz, J.P. A. Samijn et al.Neurology, November 01, 1999 -
Editorial
Reevaluating clinical measurement tools in therapeutic trialsTime to make a Rasch decision?A. Gordon Smith, Ted M. Burns et al.Neurology, November 05, 2014